Mark Andrew Wilson Nektar Therapeutics (NKTR) insider trading activity

NKTR Quotes by TradingView

Mark Andrew Wilson is Chief Legal Officer of NEKTAR THERAPEUTICS. Currently has a direct ownership of 21,585 shares of NKTR, which is worth approximately $1.22 Million. The most recent transaction as insider was on May 17, 2021, when has been sold 1,917 shares (Common Stock) at a price of $18.3 per share, resulting in proceeds of $35,081. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.6K
6.27% 3M change
93.56% 12M change
Total Value Held $1.22 Million

Mark Andrew Wilson Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2021
SELL
Open market or private sale
$35,081 $18.3 p/Share
1,917 Reduced 2.5%
74,810 Common Stock
Feb 16 2021
SELL
Open market or private sale
$48,610 $22.37 p/Share
2,173 Reduced 2.75%
76,727 Common Stock
Feb 03 2021
SELL
Open market or private sale
$103,941 $19.45 p/Share
5,344 Reduced 6.34%
78,900 Common Stock
Feb 03 2021
SELL
Exercise of conversion of derivative security
$47,027 $8.8 p/Share
5,344 Reduced 5.97%
84,244 Common Stock
Dec 18 2020
BUY
Grant, award, or other acquisition
-
28,550 Added 26.57%
78,900 Common Stock
Nov 16 2020
SELL
Open market or private sale
$26,055 $16.93 p/Share
1,539 Reduced 2.99%
49,850 Common Stock
MAW

Mark Andrew Wilson

Chief Legal Officer
San Francisco, CA

Track Institutional and Insider Activities on NKTR

Follow NEKTAR THERAPEUTICS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

News

Receive news related to NEKTAR THERAPEUTICS

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NKTR